Apeak Biotechnologies Private Limited
About Apeak Biotechnologies Private Limited
Data last updated:
Apeak Biotechnologies Private Limited is a private limited company based in New Delhi, Delhi, India. The company is currently under process of striking off by the Registrar of Companies. The removal process has been initiated but is not yet final, and the company may be struck off soon. It operates in the speciality chemicals segment of the chemicals sector. It was incorporated on 21 April 2004.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2004PTC125949.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kuldeep Kaur and Satvinder Kaur.
Its last annual general meeting (AGM) was held on 25 August 2008, and its latest financial statements are for the year ended 31 March 2008. The registered office is at 111 Okhla Industrial Estatephase III, New Delhi, Delhi, India – 110020.
Company details
Contact details
Apeak Biotechnologies Private Limited's registered office is in New Delhi, Delhi.
- Registered Address111 Okhla Industrial Estatephase III, New Delhi, Delhi, India – 110020
- IndustryChemicals, Other Chemical Product, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Apeak Biotechnologies Private Limited
FY 2008 filings availableFinancial Statement Summary
| Metrics | FY 2007-08 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2007-08 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Apeak Biotechnologies Private Limited, buy the company report.
Board of directors of Apeak Biotechnologies Private Limited
Apeak Biotechnologies has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kuldeep Kaur | Director | 21 Apr 2004 | 22 Years 6 Months | Current |
| Satvinder Kaur Also directs: As Retailer LLP, Baba Venntures Private Limited, Appreciate Fincaap Private Limited and 1 more | Director | 21 Apr 2004 | 22 Years 6 Months | Current |
Legal cases
No court or tribunal cases involving Apeak Biotechnologies Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Apeak Biotechnologies Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Apeak Biotechnologies Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Apeak Biotechnologies Private Limited has 2 board changes on record since 2004: 2 appointments. The latest: Kuldeep Kaur was appointed as Director on 21 Apr 2004.
Frequently asked questions
Apeak Biotechnologies is currently "Under Process of Striking Off" as per MCA records. The Registrar of Companies has initiated the process to remove the company from the register, typically due to non-filing of statutory returns. This process is not yet final, but the company may be struck off soon. Caution is advised before entering into any agreements with this entity.
Apeak Biotechnologies is a company pending strike off, currently registered as a private limited company based in New Delhi, Delhi, India. The company works in other chemical product, within the chemicals industry. It was incorporated on 21 April 2004 and is registered under CIN U24239DL2004PTC125949. The company may be struck off soon - caution is advised.
Apeak Biotechnologies has 2 current directors:
- Kuldeep Kaur - Director
- Satvinder Kaur - Director
The CIN (Corporate Identification Number) of Apeak Biotechnologies is U24239DL2004PTC125949. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apeak Biotechnologies was incorporated on 21 April 2004. It is registered with the Registrar of Companies, Delhi.
The registered office of Apeak Biotechnologies is at 111 Okhla Industrial Estatephase III, New Delhi, Delhi, India – 110020.
The latest financial statements of Apeak Biotechnologies on record with the MCA are for the year ended 31 March 2008. Its last annual general meeting was held on 25 August 2008. Year-wise statements from 2015 are in the company report.
Apeak Biotechnologies operates in the chemicals industry, in the other chemical product segment.
Kuldeep Kaur was appointed as Director on 21 Apr 2004. Satvinder Kaur was appointed as Director on 21 Apr 2004.
Apeak Biotechnologies can be reached at its registered office: 111 Okhla Industrial Estatephase III, New Delhi, Delhi, India – 110020.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
